Adverse events and reactions to antimalarials in patients with rheumatoid arthritis during observation period
| AE/AR | Patients without CVD/PH (n=249) | Patients with previous CVD/PH (n=95) | Total n=344 (%) |
| Retinal toxicity | 100 | 30 | 130 (37.9) |
| Gastrointestinal AEs | 83 | 20 | 103 (30.0) |
| Dermatological ARs | 65 | 45 | 110 (31.8) |
| Severe dizziness | 1 | 0 | 1 (0.3) |
| CVD AEs/ARs | 0 | 0 | 0 (0.0) |
AE, adverse event; AR, adverse reaction; CVD, cardiovascular disease; PH, primary hypertension.